NovaBay Pharmaceuticals Partners With Woo University To Educate Eyecare Professionals On The Use Of Amniotic Membranes
Portfolio Pulse from Benzinga Newsdesk
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) has partnered with Woo University to offer a free educational webinar for eyecare professionals on the use of amniotic membranes. The webinar is scheduled for December 7, 2023. This initiative follows the commercial launch of NovaBay's Avenova Allograft in September 2023, a prescription amniotic membrane product for ocular surface repair.
December 06, 2023 | 11:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NovaBay Pharmaceuticals partners with Woo University to educate eyecare professionals on amniotic membranes, leveraging its Avenova Allograft product.
The partnership with Woo University for educational purposes is likely to increase the visibility and credibility of NovaBay's Avenova Allograft among eyecare professionals, potentially leading to increased adoption and sales. This positive marketing move could have a favorable impact on NBY's stock in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80